These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2877889)

  • 41. The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.
    Plantjé JF; Hansen HA; Daus FJ; Stoof JC
    Eur J Pharmacol; 1984 Oct; 105(1-2):73-83. PubMed ID: 6208045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G; Giardi A; Raiteri M
    J Pharmacol Exp Ther; 1988 Nov; 247(2):680-4. PubMed ID: 2903237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A; Rakovska A; Görcs T; Vizi ES
    Brain Res; 1993 May; 612(1-2):306-12. PubMed ID: 8101133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminergic regulation of striatal acetylcholine release: importance of D1 and N-methyl-D-aspartate receptors.
    Damsma G; Robertson GS; Tham CS; Fibiger HC
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1064-72. PubMed ID: 1837058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists.
    Carlson JH; Bergstrom DA; Walters JR
    Eur J Pharmacol; 1986 Apr; 123(2):237-51. PubMed ID: 2940101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
    Henselmans JM; Hoogland PV; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine D-1 and D-2 receptor agonists and antagonists and neuropeptide-induced excessive grooming.
    Van Wimersma Greidanus TB; Maigret C; Torn M; Ronner E; Van der Kracht S; Van der Wee NJ; Versteeg DH
    Eur J Pharmacol; 1989 Dec; 173(2-3):227-31. PubMed ID: 2576230
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.
    Scatton B
    J Pharmacol Exp Ther; 1982 Jan; 220(1):197-202. PubMed ID: 6118430
    [No Abstract]   [Full Text] [Related]  

  • 51. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
    Apud JA; Masotto C; Ongini E; Racagni G
    Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
    Henselmans JM; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):1-7. PubMed ID: 1687661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine D2 receptor mediation of the discriminative stimulus properties of LY 171555 (quinpirole).
    Weathersby RT; Appel JB
    Eur J Pharmacol; 1986 Dec; 132(1):87-91. PubMed ID: 2949989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
    Santiago M; Westerink BH
    Eur J Pharmacol; 1991 Oct; 204(1):79-85. PubMed ID: 1687125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.
    Jiang HK; McGinty JF; Hong JS
    Brain Res; 1990 Jan; 507(1):57-64. PubMed ID: 1967976
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
    Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
    J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum.
    Acquas E; Di Chiara G
    Eur J Pharmacol; 1999 Nov; 383(3):275-9. PubMed ID: 10594319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.